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Introduction
During mammalian cleavage, the egg divides to form a
spherical blastocyst comprising an outer unilaminar
epithelium, the trophectoderm, which generates the blastocoel
cavity by polarized ion and water transport, and surrounds the
undifferentiated inner cell mass (ICM; fetal progenitor).
Subsequently, the trophectoderm initiates attachment and
invasion of uterine endometrium at implantation and gives rise
to the chorio-allantoic placenta. Trophectoderm differentiation
in the mouse begins at compaction at the eight-cell stage when
both intercellular adhesion between blastomeres mediated by
E-cadherin and apico-basal cell polarity occur and is complete
by the 32-cell stage, some 24 hours later, during which time a
mature, fully polarized epithelial phenotype is generated,
culminating in blastocoel fluid accumulation in the embryo
interior (for reviews, see Fleming et al., 2001; Watson and
Barcroft, 2001). Mouse trophectoderm is a useful model for
unravelling steps in the epithelial differentiation process that
cannot realistically be investigated in established cell lines
(e.g. MDCK cells), in which cells are already mature and
manipulated experimentally. Here, we consider cell
polarization and particularly the construction of the zonular
tight junction (TJ) between trophectoderm cells, an
intercellular barrier essential for maintenance of membrane
polarity and regulation of paracellular permeability (for a
review, see Gonzalez-Mariscal et al., 2003). In the context of
early morphogenesis, TJ biogenesis provides the means to
control the microenvironment of the ICM via trophectoderm
transport pathways for ions, amino acids, energy substrates,
growth factors and other metabolites.
TJs are composed of several interacting proteins localized as
a belt around the apex of each epithelial cell, above the E-
cadherin-rich zonular adherens junction (AJ). In freeze-
fracture P-face replicas, TJs appear as rows of branching
strands composed of intramembraneous particles that, in thin
section, constitute sites of close cell-cell membrane apposition
(Gonzalez-Mariscal et al., 2003). So far, three groups of
transmembrane proteins have been identified within TJs:
occludin (Furuse et al., 1993); claudin family members (Furuse
et al., 1998); and junctional adhesion molecule (JAM) (Martin-
Padura et al., 1998; Bazzoni, 2003).
Occludin and claudins are unrelated proteins that traverse
the membrane four times with two extracellular loops and
intracellular N- and C-termini, the latter interacting with a
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We have investigated the contribution of the tight junction
(TJ) transmembrane protein junction-adhesion-molecule 1
(JAM-1) to trophectoderm epithelial differentiation in the
mouse embryo. JAM-1-encoding mRNA is expressed early
from the embryonic genome and is detectable as protein
from the eight-cell stage. Immunofluorescence confocal
analysis of staged embryos and synchronized cell clusters
revealed JAM-1 recruitment to cell contact sites occurred
predominantly during the first hour after division to the
eight-cell stage, earlier than any other TJ protein analysed
to date in this model and before E-cadherin adhesion and
cell polarization. During embryo compaction later in the
fourth cell cycle, JAM-1 localized transiently yet precisely
to the apical microvillous pole, where protein kinase C z
(PKCz ) and PKCd are also found, indicating a role in cell
surface reorganization and polarization. Subsequently, in
morulae and blastocysts, JAM-1 is distributed ubiquitously
at cell contact sites within the embryo but is concentrated
within the trophectoderm apicolateral junctional complex,
a pattern resembling that of E-cadherin and nectin-2.
However, treatment of embryos with anti-JAM-1-
neutralizing antibodies indicated that JAM-1 did not
contribute to global embryo compaction and adhesion but
rather regulated the timing of blastocoel cavity formation
dependent upon establishment of the trophectoderm TJ
paracellular seal.
Key words: Junction adhesion molecule, Tight junction,
Trophectoderm epithelium, Cell polarity, Blastocyst, Adherens
junction.
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series of cytoplasmic plaque proteins that link the TJ to the
actin cytoskeleton. Claudins form a multigene family with
different members expressed and localized to TJs in distinct
tissues, where they constitute the major component of the
freeze-fracture strands and the inherent tissue-specific
variability in paracellular barrier function (Tsukita et al., 2001;
Gonzalez-Mariscal et al., 2003). However, occludin is encoded
by a single gene and has also been shown to contribute to TJ
intercellular adhesion and membrane polarity (Van Itallie and
Anderson, 1997; Wong and Gumbiner, 1997; Gonzalez-
Mariscal et al., 2003).
JAM-1 (36-41 kDa) is present at epithelial and endothelial
TJs (Martin-Padura et al., 1998) as well as on platelets and cells
of the peripheral lymphoid organs (Malergue et al., 1998;
Williams et al., 1999). Unlike occludin and claudins, it is a
single-membrane-span immunoglobulin (Ig)-like protein with
two variable extracellular Ig domains and a short C-terminal
cytoplasmic tail through which it interacts with TJ plaque and
associated proteins, notably AF6 (Ebnet et al., 2000),
ASIP/Par-3 (Itoh et al., 2001; Ebnet et al., 2001), ZO-1
(Bazzoni et al., 2000a), MUPP1 (Hamazaki et al., 2002),
CASK (Martinez-Estrada et al., 2001) and cingulin (Bazzoni
et al., 2000a; Ebnet et al., 2000). Structural and biochemical
studies indicate that JAM-1 forms inverted U-shaped dimers
within the plane of the membrane via interactions between
adjacent extracellular N-termini; the dimers in turn engage in
homophilic interactions that might form the basis for
homotypic intercellular adhesion (Bazzoni et al., 2000b;
Kostrewa et al., 2001; Bazzoni, 2003). The intercellular
adhesive function of JAM-1 at the TJs contributes to the
restriction of paracellular permeability in epithelia (Liu et al.,
2000) and appears to facilitate leukocyte transmigration
between vascular endothelial cells, possibly mediated by JAM-
1 binding to integrins, because a monoclonal antibody against
JAM-1 extracellular domain (BV11) inhibited such migration
(Martìn-Padura et al., 1998; Bazzoni, 2003). JAM-1 is also
implicated in the development of epithelial cell and membrane
polarity through its association with ASIP/Par-3, which can
recruit atypical protein kinase C (PKC) to the junction site
(Itoh et al., 2001; Ebnet et al., 2001). Furthermore, JAM-1
might contribute to AJ formation, because it associates with
the nectin calcium-independent adhesion complex, which in
turn is involved in the organization and velocity of assembly
of the E-cadherin-rich AJ (Takai and Nakanishi, 2003;
Tachibana et al., 2000; Fukuhara et al., 2002; Honda et al.,
2003). JAM-1 homologs (JAM-2, JAM-3 and JAM-4) have
recently been identified in endothelial/epithelial cells and
leukocyte membranes, and might contribute to paracellular
transmigration (Cunningham et al., 2000; Arrate et al., 2001;
Aurrand-Lions et al., 2001; Hirabayashi et al., 2003). A new
nomenclature for JAMs has been proposed in which JAM-1 is
referred to as JAM-A (Bazzoni, 2003).
The relevance of the mouse trophectoderm model for
epithelial differentiation is evident in that cell polarization and
TJ biogenesis are multistep processes that allow the contribution
of specific gene products to specific events to be evaluated. Thus,
TJ biogenesis in the mouse embryo occurs in three phases
corresponding to the eight-cell, 16-cell and early-32-cell stages
when constituents assemble at the apicolateral membrane
contact site, largely regulated by temporal control of constituent
gene expression and post-translational events (Fleming et al.,
2001). Notably, E-cadherin adhesion at compaction is crucial for
polarized membrane recruitment of TJ proteins and, until the 32-
cell stage, TJ constituents localize with the AJ, the two junctions
only becoming molecularly distinct once occludin and specific
claudins assemble as a final event in TJ construction, apparently
mediated by late transcription of the cytoplasmic binding partner
ZO-1a + isoform (Sheth et al., 1997; Sheth et al., 2000a; Sheth
et al., 2000b; Fleming et al., 2001) (F.C.T., B.S. and T.P.F.,
unpublished).
Here, we report the contribution of JAM-1 in the mouse
embryo to epithelial differentiation and offer new insight into
the mechanisms of cell polarization and biogenesis of AJ and
TJ in this model. Significantly, we find that JAM-1 membrane
assembly occurs before that of any other recognized TJ
constituent so far investigated in this model and, indeed, before
compaction, indicating independence of its assembly from E-
cadherin adhesion. JAM-1 also becomes intimately associated
with the process of cell polarization at the eight-cell stage, when
it localizes transiently and precisely with the apical microvillous
pole, coincident with apical membrane localization of specific
PKC isoforms. Subsequently, JAM-1 is expressed and localized
to contact sites between cells in both trophectoderm and ICM
lineages of the morula and blastocyst, coincident with
trophectoderm expression of the nectin adhesion system,
suggesting a broad role in early morphogenesis. However,
through the use of neutralizing antibodies, we show that JAM-
1 does not contribute to global intercellular adhesion within the
embryo but rather to trophectoderm TJ paracellular sealing and
the timing of blastocoel cavitation.
Materials and Methods
Embryo collection, culture and manipulation
4-5-week-old MF1 mice (Olac-derived, Southampton University
Biomedical Facility) were superovulated by intraperitoneal injections
of 5-10 IU per 0.1-0.2 ml pregnant mares’ serum (PMS; Folligon,
Intervet) and then 5-10 IU per 0.1-0.2 ml human chorionic
gonadotrophin (hCG; Chorulon, Intervet) 48 hours later. Immediately
following the hCG injection, females were either mated with sexually
mature males of the same strain or left unmated for unfertilized egg
collection. Cumulus masses were collected at 18-20 hours after hCG
injection for isolation of unfertilized or fertilized eggs by removal of
cumulus cells using a flame-polished micropipette following
incubation with hyaluronidase [300 m g ml–1 in H6 medium with 4 mg
ml–1 bovine serum albumin (BSA)] for 10 minutes at 37°C as
described previously (Fleming et al., 2002).
Embryos were flushed at the late two-cell stage (approximately 48
hours after hCG) from dissected oviducts using H6 medium
containing 4 mg ml–1 BSA and cultured in T6 plus 4 mg ml–1 BSA
until required at 37°C in 5% CO2 in air (Fleming et al., 2002). Two-
cell, four-cell (~55 hours after hCG injection) and early and compact
eight-cell embryos (70-75 hours after hCG injection) were identified
using morphological criteria. To obtain synchronized pools of recently
divided eight-cell embryos, late four-cell embryos (~65 hours after
hCG injection) were observed hourly and newly formed eight-cell
embryos (designated 0 hours after division) were collected and
separately cultured. Synchronized pools of newly compact eight-cell
embryos were similarly obtained by hourly inspection of stock
cultures. The 16-cell embryos were staged by selecting newly
compacting eight-cell embryos and culturing them separately for 10-
12 hours (~80-85 hours after hCG injection); late morula (~32-cell
stage; ~90 hours after hCG injection) were staged by culturing
compact eight-cell embryos for 20-24 hours. Early and late blastocysts
were timed from hCG injection (~96 and ~116 hours, respectively).
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To obtain synchronized embryo-cell clusters, late four-cell embryos
were disaggregated to single cells as described previously (Fleming
et al., 2002). Briefly, embryos were treated with acid Tyrodes medium
to remove the zona pellucida and incubated in Ca2+-free medium for
15 minutes before disaggregation into single blastomeres (now called
1/4 blastomeres) using a small, heat-polished glass micropipette.
Groups of five 1/4 blastomeres were cultured in individual 10 m l drops
of T6 plus BSA and checked hourly for division into 2/8 couplets,
which were separately cultured until required.
Reverse-transcription polymerase chain reaction
For the reverse-transcription polymerase chain reaction (RT-PCR),
tissue samples were dissected from freshly culled mice, cut into ~1
mm cubes and snap frozen in microfuge tubes. Total RNA was
isolated from them using the RNeasy miniprep kit (Qiagen, UK) after
samples were homogenized in the kit buffer. Eggs and embryos were
processed to extract either poly(A)+ RNA or total RNA. For poly(A)+
RNA, groups of five or ten eggs or embryos of appropriate stage were
washed three times in PBS containing 0.3% polyvinylpyrrolidone
(PBS+PVP), placed in a 1 m l drop of sterile PBS, snap frozen on dry
ice in a siliconized 0.5 ml microfuge tube (Costar) and stored at
–70°C. Poly(A)+ RNA was extracted from freshly thawed samples
using the Dynabeads mRNA DIRECT Kit (Dynal, UK) according to
the manufacturer’s instructions with minor modifications (Eckert and
Niemann, 1998). Poly(A)+ RNA was eluted in 9 m l nuclease-free
water before addition to a 20 m l RT reaction comprising 1 mM of each
dNTP (Amersham), 2.5 m M random hexamers (Perkin-Elmer) or 1
m M specific antisense primer, 10 U RNase inhibitor (Perkin-Elmer)
and 25 U Moloney murine leukemia virus reverse transcriptase
(Perkin-Elmer) or Sensiscript (Qiagen) enzyme. RT reactions were
incubated for 10 minutes at 25°C, 60 minutes at 42°C and 5 minutes
at 99°C, and then cooled to 4°C. For total RNA extraction, batches of
five eggs and blastocysts were lysed and the RNA extracted using
the Absolutely RNA Ô Nanoprep Kit (Stratagene) according to
manufacturer’s instructions. The 20 m l RT comprised 0.5 mM dNTP
mix (Qiagen), 0.16 m M random hexamers (Perkin-Elmer), 0.1 m M
oligo-dT (Invitrogen), 10 U RNase inhibitor (Perkin-Elmer) and 1 m l
Sensiscript enzyme (Qiagen). The reaction was incubated at 37°C for
1 hour and 5 minutes at 93°C, and then cooled to 4°C. cDNA
equivalent to one egg per embryo was then used in a PCR reaction
(described below).
After the RT reaction, 2-20 m l was transferred as template to a 50 m l
PCR reaction comprising 1 · PCR buffer (Gibco BRL), 1.5 mM
MgCl2, 200 m M each dNTP and 1 m M each sequence-specific primer.
These comprised the sense (GAGGGGAAAGCCGGGAGGAAACT-
GT, positions 80-104) and antisense (CAAAGGCTGTCACGGGGT-
CAAAGAT, positions 662-686) primers based on the mouse cDNA
sequence (GenBank accession number U89915), which spanned
intron sequences to ensure that there was no amplification of genomic
DNA. During the hot start (99°C for 5 minutes and 72°C for 2
minutes), 2 U Taq DNA polymerase (Gibco) were added at 72°C.
Amplification of cDNA was carried out for 35-40 cycles comprising
95°C for 30 seconds, 60°C for 30 seconds and 72°C for 45 seconds,
followed by a 5 minute final extension at 72°C. Reaction products
were run on 0.5 · TBE 2% agarose gels stained with ethidium
bromide. Reaction products were prepared for sequencing using a
QIAquick gel extraction protocol (Qiagen) after removal from the
agarose gel and used in BigDye cycle sequencing protocols according
to the manufacturer’s instructions on an ABI377 sequencer (Applied
Biosystems). Sequences were analysed using the Chromas software
and identified by Blast search on the NCBI website
(http://www.ncbi.nlm.nih.gov/BLAST/).
Immunofluorescence and confocal microscopy
Zona-free embryos were fixed in either 1% or 4% formaldehyde in
PBS or in ice-cold methanol, attached to coverslips within processing
chambers pretreated with 1 mg ml–1 poly-L-lysine hydrobromide
(Sigma) or 0.1 mg ml–1 Concanavalin A (Sigma) in PBS, respectively,
and processed for immunocytochemistry as described previously
(Fleming et al., 2002). Staged embryos were stained with DECMA-1
(rat monoclonal anti-mouse E-cadherin, 1:1000; Sigma), BV12 (rat
monoclonal anti-mouse-JAM-1 antibody, 0.1 m g ml–1) (Martin-Padura
et al., 1998), BV20 (rat monoclonal anti-mouse JAM-1 antibody, 10
m g ml–1) (Bazzoni et al., 2000b), PKC isoform-specific polyclonal
antibodies against rat sequences (atypical PKCs i /l and z and novel
PKCs d , m and q ; 1:200 or 1:500) as detailed elsewhere (Eckert et al.,
2004a) or anti-nectin-2 antibody (rat monoclonal anti-Nectin-2
antibody, 1 m g ml–1; Cambridge Bioscience) in PBS containing 0.1%
Tween 20 (PBS:Tween-20) overnight at 4°C. Chambers were washed
three times over 30 minutes and labeled with a 1:500 dilution of
Alexa-488- or -546-labelled anti-rat secondary antibody (Molecular
Probes) for 1 hour. Chambers were rewashed three times over 30
minutes in PBS:Tween-20 and samples mounted in anti-fadant PBS-
Citifluor (Citifluor, London). Rhodamine phalloidin (Molecular
Probes; 6.6 m M stock in methanol) was used for co-labeling of actin
filaments when required during the second PBS:Tween-20 wash (0.5
m l ml–1) after the secondary antibody incubation. Embryos were
visualized using a 63· oil-immersion objective on a Nikon inverted
microscope linked to a Bio-Rad MRC-600 series confocal imaging
system, equipped with a Krypton-Argon laser and K1/K2 filter sets.
Images were analysed and processed by the Bio-Rad software system
(Confocal assistant, Version 4.01).
Electrophoresis and immunoblotting
Mouse lung tissue was snap frozen in liquid nitrogen, ground to
powder on dry ice, immediately boiled in 1% sodium dodecyl sulfate
(SDS) in PBS for 5 minutes followed by centrifugation at 10,000 g
for 10 minutes and storage of supernatant at –70°C. Pools of precisely
staged embryos were washed three times in H6 medium plus 6 mg
ml–1 polyvinylpyrrolidone and solubilized either in boiling 2 · SDS
sample buffer or 4· Novex sample buffer (Invitrogen) for 3-5 minutes,
centrifuged at 10,000 g and stored at –70°C. Protein concentrations
of tissue samples were determined using the Lowry method (DC
Protein Assay, BioRad). Embryo and tissue samples were heated to
95°C for 5 minutes and briefly centrifuged at 10,000 g before
electrophoresis on pre-cast 4-12% gradient TB-buffered gels with
MOPS buffers (Invitrogen) and blotted onto Hybond-C nitrocellulose
(Amersham). Blots were blocked with 5-10% non-fat dried-milk
powder in PBS containing 0.05-0.10% Tween 20 before incubation in
BV20 antibody (10 m g ml–1) in blocking buffer for 1 hour. Blots were
washed three times in PBS containing 0.05-0.10% Tween 20,
incubated in horseradish-peroxidase (HRP)-conjugated rabbit anti-rat
secondary antibody (Sigma) for 1 hour, and washed three further times
before being developed with SuperSignal Ò West PICO (Pierce) kit and
visualized on ECL hyperfilm (Amersham Biosciences).
Functional analyses
Embryos were staged from the onset of the eight-cell stage or from
the start of compaction and incubated in T6 plus BSA containing 5 m g
ml–1 BV11 or BV12 anti-JAM-1 antibodies (mouse monoclonal
IgG2b class) for various culture periods. Control medium contained
an equivalent concentration of mouse IgG2b anti-CD21 (lymphocyte-
specific) kindly provided by A. Al-Shamkhani (University of
Southampton, School of Medicine). Alternatively, embryos were
treated with anti-E-cadherin antibody ECCD-1 (1:50 dilution of
serum) (Shirayoshi et al., 1983), a known inhibitor of embryo
compaction (Johnson et al., 1986) kindly provided by M. Takeichi
(University of Kyoto, Kyoto, Japan). Antibody-containing media were
changed every 12 hours. During treatment, embryos were scored
depending on stage for either state of compaction or cavitation, at 1
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hour or 2 hour intervals. In addition, nascent blastocysts after
treatment were placed in fresh medium containing experimental or
control antibody plus 1 mg ml–1 FITC/dextran 4 kDa (Sigma) and
examined by confocal microscopy as described previously to
determine the state of paracellular permeability (Sheth et al., 2000a).
Statistics
Rates of compaction and cavitation in embryo groups were compared
by ‘time to event’ analysis using a Wilcoxon test stratified for
experiment. P values less than 0.05 were regarded as significant.
Results
JAM-1 is expressed at the onset of epithelial
differentiation
JAM-1-encoding mRNA expression was not detected by RT-
PCR using poly(A)+ RNA extracted from unfertilized or
fertilized eggs but was readily amplified from embryos at all
stages from two-cell to late blastocyst (five eggs or embryos
per sample) with stronger signals evident from the eight-cell
stage onwards (Fig. 1A). JAM-1 transcripts before the two-cell
stage were also undetectable using poly(A)+ RNA in ten
embryo samples with an increased PCR cycle number (data not
shown). However, using total RNA as starting material, JAM-
1-encoding mRNA was readily identified in unfertilized eggs
and blastocysts even at one egg or embryo per sample (Fig.
1A), suggesting that polyadenylation of JAM-1 transcripts
might occur as development proceeds. JAM-1 protein
production in fertilized eggs was examined by immunoblotting
up to late blastocyst stages. JAM-1 protein was not detected in
samples up to and including the pre-compact eight-cell
embryo. Weak expression was evident in compact eight-cell
embryos and increased in later stages examined (Fig. 1B).
JAM-1 membrane assembly is independent of E-
cadherin adhesion, associated with cell polarization, and
initiates TJ biogenesis
JAM-1 localization was examined by immunfluorescence
confocal microscopy using the BV12 anti-JAM-1 antibody in
unfertilized eggs to late-blastocyst stages with E-cadherin
staining used as a marker of AJ protein in a parallel set of
samples (Fig. 2). Unfertilized eggs, two-cell and four-cell
embryos showed no detectable JAM-1 staining (n=8-22 per
stage), despite the presence of E-cadherin protein in eggs or
embryos of the same developmental stage (Fig. 2A-C,I-K).
JAM-1 staining was first detected in all pre-compact eight-
cell embryos (n=6) at sites of cell-cell contact (Fig. 2L). At
the onset of compaction, all eight-cell embryos (n=14) also
revealed intense JAM-1 staining at the apical poles (outward
facing) of blastomeres in addition to contact sites (Fig. 2M),
a pattern not seen for E-cadherin (Fig. 2E). At the 16-cell
morula stage, JAM-1 was again localized along lateral cell-
cell contacts with minimal or no staining evident at
microvillous poles (Fig. 2N; n=9). Cell contact membrane
localization of JAM-1 was also seen in early and late
blastocysts (n=11 for each) in both trophectoderm and ICM
lineages, and with an apicolateral concentration of JAM-1
between trophectoderm cells (Fig. 2O,P). Contact-free
trophectoderm basal membranes adjacent to the blastocoel
were also stained for JAM-1. A similar staining pattern was
evident for E-cadherin in morulae and blastocysts (Fig. 2F-
H).
Verification of polar membrane localization of JAM-1 in
compact eight-cell embryos was achieved by double labeling
for actin filaments using phalloidin to identify microvillous
poles (Johnson et al., 1986). Merged images revealed that
apical surface JAM-1 was localized with the actin-rich
microvillous poles (Fig. 3A). To determine the relative timing
of cell contact and apical membrane assembly of JAM-1,
embryos were examined at 0 hours, 3 hours, 6 hours and 9
hours after cleavage into eight-cell stage. This analysis
revealed that JAM-1 contact staining was present in most or all
embryos at all time points and preceded apical surface staining,
which was evident mainly from 6 hours after division when
compaction was occurring (Fig. 3B,C). The presence or
absence of JAM-1 staining at cell-cell contact and blastomere
poles was also investigated in timed 2/8 couplets (Fig. 4).
Again, it was evident that contact staining preceded apical-pole
staining and was present in most couplets from immediately
after division onwards. By contrast, apical staining appeared as
couplets compacted during mid-cycle (Fig. 4A,B).
JAM-1 membrane assembly coincides with maturation of
epithelial cell polarity
To explore the potential role of JAM-1 in de novo
establishment of epithelial polarity in the embryo, we
examined whether JAM-1 apical membrane assembly at
compaction was associated with a similar polarization of PKC
isoforms that might occur through JAM-1 interaction with
ASIP/Par-3 (Itoh et al., 2001; Ebnet et al., 2001). Of the two
atypical PKC isoforms, PKCz was found to localize to the apical
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Fig. 1. (A) RT-PCR analysis of the expression of JAM-1-encoding
mRNA in egg and embryo stages. The 600 bp cDNA product is
indicated by arrows. (Left) Produced using poly(A)+ RNA with five
eggs or embryos per sample. (Right) Total RNA using one egg or
embryo equivalent per sample. ‘Co’ indicates the control without the
reverse transcription step. (B) Immunoblot analysis of JAM-1 protein
expression in eggs and embryos using BV20 antibody, showing
approximately 500 eggs or embryos per lane. Mouse lung tissue (18
m g protein) was used as positive tissue control (TC). The stages are
unfertilized eggs (UF); fertilized eggs (FE) and embryos at two-cell
(2C), four-cell (4C), precompact eight-cell (8C), compact eight-cell
(C8), early morula (EM), late morula (LM), early blastocyst (EB) and
late blastocyst (LB) stages. AbC, secondary-antibody-only control.
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surface membrane at compaction,
although it was usually not confined
precisely to the central microvillous
domain (Fig. 5A). PKCz was also present
at cell contact and intracellular sites,
including the nuclear region. During later
cleavage, PKCz is localized with the TJ
marker ZO-1a + at cell contact sites in the
trophectoderm (Eckert et al., 2004b). By
contrast, the atypical PKCi /l displayed
only intracellular cytoplasmic staining in
compact eight-cell embryos (Fig. 5A),
although it later localizes with the TJ in
blastocyst trophectoderm (Eckert et al.,
2004b). Compact eight-cell embryos were
also screened for the localization of the
novel PKC isoforms d , m and q . Of these,
PKCd revealed a striking staining pattern,
localizing predominantly to the polar
domain of the apical surface as well as to
cell contact and intracellular sites (Fig.
5A). These data indicate that polarized
JAM-1 staining at compaction coincides
with a polarized distribution of select
atypical and novel PKC isoforms.
We also investigated whether the
relatively ubiquitous distribution of JAM-
1 during morula and blastocyst formation
(present at cell contact sites in both
trophectoderm and ICM, like E-cadherin,
and not restricted to trophectoderm TJs)
might signify a role in maturation of the
AJ during this period. The calcium-
independent nectin adhesion complex has
been shown to enhance E-cadherin-
mediated adhesion and AJ maturation in
non-developmental models and interacts
directly with JAM-1 through the nectin cytoplasmic domain
protein, afadin (Takai and Nakanishi, 2003; Tachibana et al.,
2000; Fukuhara et al., 2002; Honda et al., 2003). We therefore
examined the expression of nectin-2, a ubiquitous member of the
nectin family, during early development. It was undetectable by
immunofluorescence before compaction, when faint,
discontinuous staining at cell contact sites was apparent (Fig.
5B). In morula and blastocyst stages, stronger nectin-2 staining
was present, mainly within apicolateral cell contact sites within
trophectoderm but also weakly at contact sites in the ICM (Fig.
5B). These data show a close correlation between JAM-1, E-
cadherin and nectin-2 localization during later cleavage,
indicative of a maturation in AJ structural identity. However,
early assembly of JAM-1 during the eight-cell stage and E-
cadherin throughout cleavage are unlikely to be mediated by
nectin-2.
JAM-1 stimulates tight junction sealing and blastocyst
formation but not global cell-cell adhesion in the embryo
Neutralizing-antibody incubation experiments were conducted
to evaluate the relative contribution of JAM-1 to AJ and TJ
adhesion in the embryo. Embryos were staged from the
beginning of the eight-cell stage and cultured for up to 9 hours
in the presence of anti-JAM-1 neutralizing antibodies BV11 or
BV12, or in control medium containing an equal concentration
of another IgG2b-class antibody (against CD21, a lymphocyte
antigen not expressed in preimplantation embryos). Embryos
underwent compaction at equivalent rates during the first 6
hours of culture in all three treatments (Fig. 6A). Newly
compacted eight-cell embryos and later-stage morulae were
also cultured in the presence of JAM-1 or control antibodies
and, in all cases, the compacted state was maintained, whereas
compact embryos cultured in an E-cadherin-neutralizing
antibody (ECCD-1) fully decompacted within 20 minutes of
treatment (data not shown). These results indicate that JAM-1
cell-surface expression does not contribute to initiation or
maintenance of cell adhesion within the embryo.
To evaluate the role of JAM-1 in blastocoel formation
dependent upon TJ integrity, newly compacted eight-cell
embryos were cultured in the presence of anti-JAM-1 or
control antibodies for up to 48 hours (Fig. 6B). Here, both
BV11 and BV12 treatment had no effect on global embryo
adhesion but significantly reduced the rate of cavitation
compared with control embryos (P<0.0001 and P<0.005,
respectively). Nascent blastocysts (up to 2 hours after the onset
of cavity formation) incubated with anti-JAM-1 or control
antibody from compaction were examined by confocal
Fig. 2. Immunofluorescence confocal microscopy of E-cadherin (A-H) and JAM-1 (I-P)
staining patterns during preimplantation development. The stages are unfertilized eggs (UF)
and embryos at two-cell (2C), four-cell (4C), precompact eight-cell (8C), compact eight-cell
(C8C), morula (Mor), early blastocyst (EB) and late blastocyst (LB) stages. Bar, 20 m m.
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microscopy for evidence of
paracellular permeability by
exclusion of FITC-dextran. FITC-
dextran penetration into the
blastocoel cavity was evident in a
similar proportion of JAM-1
(BV11, 33%, n=52; BV12, 23%,
n=47) and control (IgG2b, 29%,
n=68) antibody-treated embryos.
These data indicate that JAM-1
intercellular adhesion contributes
to the trophectoderm TJ
permeability barrier required for
blastocoel cavity formation but
that, once blastocysts are formed in the presence
of anti-JAM-1 antibodies, they have normal
effective TJs.
Discussion
We have investigated the contribution of JAM-1
to mouse trophectoderm differentiation and
blastocyst formation, and identified several novel
features in its expression and activity that give new
insight into mechanisms of differentiation and TJ
biogenesis. First, detection of JAM-1-encoding
mRNA within unfertilized eggs was only possible using total
rather than poly(A)+ RNA; using the latter material, JAM-1
transcripts were first detected at the two-cell stage, when the
embryonic genome is mainly activated, with increasing cDNA
amplification apparent at progressively later stages of cleavage
(Fig. 1A). These data might indicate maternal expression
of a poorly adenylated JAM-1-encoding mRNA, with
polyadenylation coinciding with embryonic transcription.
Deadenylation and subsequent polyadenylation of mRNAs are
recognized mechanisms of translational repression and
initiation, respectively, in the mouse oocyte during maturation,
following fertilization and at the onset of embryogenesis (for
a review, see Eichenlaub-Ritter and Peschke, 2002). The
apparent depletion of polyadenylated JAM-1-encoding mRNA
in mouse eggs is unexpected because transcripts for most other
epithelial TJ genes analysed to date (ZO-1 a – isoform, ZO-2,
rab13, cingulin, occludin) are readily detectable in mouse egg
poly(A)+ RNA (Sheth et al., 1997; Sheth et al., 2000a; Sheth
et al., 2000b) (B.S. and T. P. F., unpublished).
We recently examined JAM-1 expression in bovine eggs and
embryos using poly(A)+ RNA and found a similar temporal
pattern, with JAM-1-encoding transcripts detectable in only a
small minority of germinal vesicle and in-vitro-matured
metaphase-II oocytes and, when present, barely detectable using
semiquantitative methods (Miller et al., 2003). Likewise, we
have found that only a minority of cultured human embryos
before the eight-cell stage (presumed maternal genome) (Braude
et al., 1988) exhibit JAM-1-encoding mRNA within poly(A)+
RNA compared with later cleavage when the transcript is readily
detectable (Ghassemifar et al., 2003). Collectively, these data
suggest that JAM-1-encoding mRNA across species might
exhibit stage-dependent differential processing to regulate the
early timing of its translation and protein membrane assembly
relative to other TJ constituents. This might reflect a critical role
for JAM-1 protein in cell polarization at compaction and
subsequent TJ biogenesis (discussed below).
Data obtained from embryo immunoblotting (Fig. 1B)
demonstrated that JAM-1 protein expression is first detectable in
compact eight-cell embryos, increasing in late morulae and
in early and late blastocysts. Immunolocalization data
demonstrated unambiguously that JAM-1 protein is first
assembled at the membrane in pre-compact eight-cell embryos,
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Fig. 3. (A) Co-localization of JAM-1
and actin (phalloidin staining) at the
apical pole (arrows) in compact eight-
cell embryos. (B) JAM-1 localization
in representative eight-cell embryos at
0 hours, 3 hours, 6 hours and 9 hours
after division in z-axis series (z) and
single mid-plane (mp) sections. Bar,
20 m m. (C) Timing of cell-cell contact
and apical polar staining of JAM-1 in
eight-cell embryos at different times
during the fourth cell cycle (n=30-40
embryos per time point; experiment
repeated four times).
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where it is found weakly localized to cell-cell contact sites. Both
in synchronized, intact eight-cell embryos and in timed 2/8
couplets, JAM-1 membrane staining at cell contacts occurred
rapidly (within an hour) after division from the four-cell stage
and clearly in advance of activation of E-cadherin adhesion at
compaction and cell polarization (Figs 3, 4). However, once
compaction occurred, JAM-1 transiently localized to the apical
microvillous pole (Fig. 3A). During later cleavage, JAM-1 was
present on all cell contact sites in both trophectoderm and ICM
lineages, although it was concentrated within the trophectoderm
apicolateral domain junctional complex (Fig. 2).
The early expression and membrane localization of JAM-1 at
contact sites before compaction is unusual in that all other TJ
proteins studied to date in the embryo differentiation model
undergo membrane assembly only after E-cadherin adhesion at
compaction has initiated (Fleming et al., 1989; Fleming et al.,
1993; Fleming et al., 2001; Sheth et al., 1997; Sheth et al., 2000a;
Sheth et al., 2000b). Indeed, experimental manipulation of E-
cadherin adhesion in embryos has indicated its requirement for
normal spatial and temporal control of TJ protein membrane
assembly and stability (Fleming et al., 1989; Javed et al., 1993;
Sheth et al., 2000b). Moreover, JAM-1 membrane recruitment
occurs substantially ahead of other TJ transmembrane proteins,
with occludin and claudin assembly occurring from the late
morula stage, some 24 hours later (Sheth et al., 2000a; Fleming
et al., 2001) (F.C.T., B.S. and T.P.F., unpublished). The early
assembly of JAM-1 indicates that it might contribute to an early
phase in epithelial differentiation, supporting the findings from
cell culture studies. Thus, JAM-1 recruitment to membranes in
Caco-2 cells after calcium addition to initiate ‘differentiation’
occurred rapidly (within minutes) and preceded that of other
junctional markers (Martinez-Estrada et al., 2001). Early JAM-
1 membrane assembly also enhanced recruitment of other TJ
proteins (ZO-1, occludin) in JAM-1-transfected CHO cells
(Bazzoni et al., 2000a).
An early role for JAM-1 in epithelial differentiation in the
embryo is also indicated by its colocalization with the newly
formed apical pole at compaction. We believe that apical
membrane localization of JAM-1 during epithelial cell
polarization has not been reported previously, although apical
(luminal) surface localization of JAM-1is required in vascular
endothelial cells to mediate leukocyte transmigration (Martin-
Padura et al., 1998). JAM-1 recruits ASIP/PAR-3 and atypical
PKC to junction sites for establishment of cell polarity in
cultured epithelial cells and JAM-1-transfected fibroblasts and
CHO cells (Itoh et al., 2001; Ebnet et al., 2001). To examine
whether JAM-1 performs a similar role in the early embryo, we
investigated the distribution of atypical (i /l , z ) and novel (d , m ,
q ) PKC isoforms at the time of compaction. Although PKC i /l
displayed only intracellular cytoplasmic staining at compaction,
PKCz was found at the apical membrane, suggesting that JAM-
1 might facilitate this localization. Apical surface PKCz at
compaction has also been reported by Pauken and Capco
(Pauken and Capco, 2000). Subsequently, both atypical PKCs
associate with the trophectoderm junctional complex in
blastocysts (Eckert et al., 2004b), to which JAM-1 is mainly
localized.
What might be the functional significance of the transient
apical membrane localization of JAM-1 and PKCz at
compaction? In addition to establishment of the epithelial
phenotype in the embryo, cell polarity at compaction is also
required for asymmetric cell divisions to occur in a proportion
of eight-cell blastomeres. These divisions give rise to
phenotypically distinct daughter cells that occupy outer and
inner locations, and are the progenitors of trophectoderm and
ICM lineages, respectively (for a review, see Fleming et al.,
2004). Thus, experimental evidence suggests that the cytocortex
associated with the apical microvillus pole at compaction acts as
a stable memory of epithelial polarity in outer cells through
subsequent mitoses as trophectoderm differentiation continues
(Johnson et al., 1988). At the molecular level, the Par gene
complex (including atypical PKCs) is implicated in the
generation of cell lineage diversity in Caenorhabditis elegans
Fig. 4. (A) JAM-1 localization in representative 2/8 couplets at 0
hours, 3 hours, 6 hours and 9 hours after division from 1/4
blastomeres. E-cadherin and negative control (secondary antibody
only) are shown at the bottom. Bar, 20 m m. (B) Timing of cell-cell
contact and apical polar staining of JAM-1 in 2/8 couplets at
different times after division from 1/4 cells (data from single
experiment comprising 39 couplets).
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and Drosophila models, and is localized asymmetrically during
differentiative divisions (for a review, see Knoblich, 2001). In
these models, cell fate diversification can occur by atypical PKC
phosphorylation of cytoskeletal components, resulting in
different inheritance of determinant proteins
(Betschinger et al., 2003). Similar to the current
study, atypical PKC is localized to the apical
membrane of blastomeres during cleavage of
Xenopus embryos, in which a role in asymmetric cell
division has been proposed (Chalmers et al., 2003).
These data on the Par gene complex indicate that
apical membrane PKCz at compaction might
contribute similarly to the process of early lineage
diversification in the mouse embryo through
cytoskeletal reorganization and cell polarity.
Extensive cytoskeletal reorganization occurs during
compaction and cell polarization in the embryo
(Johnson and Maro, 1984; Maro and Pickering,
1984) with the submembraneous microvillous pole
comprising actin and actin-binding proteins,
including myosin (Sobel, 1983), tropomyosin
(Clayton and Johnson, 1998) and ezrin (Louvet et
al., 1996), as well as the TJ protein cingulin inherited
from the oocyte (Fleming et al., 1993). In addition
to PKCz polarisation, we found the novel PKCd to
concentrate at the apical surface pole of blastomeres
at compaction. PKCd has been shown to bind F-actin
at its C2 domain in neutrophils and epithelial cells,
with experimental evidence of a function in dynamic
restructuring of the membrane-associated actin
cytoskeleton (Lopez-Lluch et al., 2001; Liedtke et
al., 2003). Conventional PKCs, in particular PKCa
at basolateral contact sites, have also been implicated
in regulating compaction through b -catenin
phosphorylation and activation of E-cadherin
adhesion by linkage to the actin cytoskeleton
(Winkel et al., 1990; Pauken and Capco, 1999;
Pauken and Capco, 2000). Cell polarity at
compaction therefore signifies a major
reorganization of the cytoskeleton with key roles for
select PKC isoforms that might contribute to
both epithelial differentiation and cell lineage
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Fig. 5. (A) Localization of PKC isoforms z , i /l and d within representative compact
eight-cell embryos (C8). Arrows indicate immunostaining at the apical membrane
domain of polarized blastomere for PKCz and d . (B) Immunolocalization of nectin-
2 (arrows) within representative compact eight-cell embryo (C8), 16-cell morula
(16-c) and blastocyst (Blast; left, mid-plane showing staining at trophectoderm
junctions and at ICM cell contacts; right, z-axis series showing trophectoderm in
tangential plane; Bl, blastocoel). n=10-20 embryos per stage or treatment in three
replicates. Bar, 20 m m.
Fig. 6. (A) Effect of embryo culture during the eight-cell stage in T6 plus BSA plus BV11 or BV12 anti-JAM-1 antibodies compared with
control IgG2b antibody (all at 5 m g ml–1) on timing of compaction (mean of 89 embryos per treatment). (B) Effect of embryo culture from
compaction in media as above on timing of cavitation (mean of 50 embryos per treatment). Rates of cavitation significantly lower than in
control medium are indicated with asterisks: *P<0.005; **P<0.0001.
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diversification. It will be of interest to determine whether
transient JAM-1 polarization at compaction is required for PKC-
mediated cellular reorganization at this time.
The co-distribution of JAM-1 and E-cadherin during morula
and blastocyst stages within trophectoderm and ICM lineages
(Vestweber et al., 1987; Clayton et al., 1993) suggests that JAM-
1 might participate in AJ formation and global adhesion within
the embryo in addition to TJ biogenesis. The E-cadherin
adhesion system is known to associate with that of the calcium-
independent immunoglobulin-like membrane protein nectin
(Takai and Nakanishi, 2003; Tachibana et al., 2000). These two
adhesion systems co-localize via interactions between their
cytoplasmic-domain binding partners (a -catenin, afadin) and
JAM-1 has recently been shown to be recruited to the nectin
complex via afadin (Fukuhara et al., 2002). Nectin adhesion is
also thought to enhance the maturation and velocity of assembly
of the E-cadherin complex (Takai and Nakanishi, 2003; Honda
et al., 2003). Thus, to explore the possibility that the broad
distribution of JAM-1 during later cleavage might reflect a
maturation of the AJ, we examined nectin expression (hitherto
not investigated in the embryo model) using an antibody against
nectin-2, a ubiquitous member of the nectin family (Takai and
Nakanishi, 2003). A close correlation was found between JAM-
1, E-cadherin and nectin-2 localization during morula and
blastocyst stages, with contact sites within trophectoderm and
ICM labeling for all three proteins. This suggests that JAM-1
membrane recruitment to these sites might be facilitated by the
nectin complex and is indicative of a structural maturation of the
AJ. However, de novo nectin-2 membrane recruitment (late
eight-cell stage) follows that of both E-cadherin (two-cell stage)
and JAM-1 (early eight-cell stage), indicating that it is not
involved in early AJ adhesion from compaction. Examination of
expression of other nectin family members in the embryo will
be required to substantiate the functional relationship between
these adhesion systems. Moreover, the early assembly of JAM-
1 relative to other TJ transmembrane proteins in the embryo
might explain the capacity for TJ plaque proteins (e.g. ZO-1a –
isoform, cingulin) to assemble before occludin and claudin
(Sheth et al., 1997; Sheth et al., 2000a; Sheth et al., 2000b;
Fleming et al., 2001).
Our functional analysis demonstrated that, despite the co-
distribution of JAM-1, E-cadherin and nectin-2, the onset and
maintenance of E-cadherin-mediated adhesion at compaction
was unaffected by anti-JAM-1 antibody embryo culture,
whereas anti-E-cadherin antibody (ECCD-1) rapidly reversed
intercellular adhesion. Thus, JAM-1 does not appear to
contribute to any significant extent to global adhesive processes
in the embryo, although molecular manipulation of JAM-1 will
be required to confirm this. By contrast, anti-JAM-1 antibody
treatment did indicate a role for JAM-1 in TJ formation in the
embryo, with evidence of significant delay in timing of
blastocoel cavity formation compared with controls indicating
a requirement for JAM-1 in the establishment of the TJ
paracellular seal. The capacity of experimental embryos to
cavitate, albeit slowly, might indicate an exclusion or titration of
antibody from basolateral surfaces owing to close cell contact.
In conclusion, our study has given new insight into the
contribution of JAM-1 to epithelial differentiation. JAM-1
expression during early development provides evidence of
involvement in cell polarity and differentiative divisions, the
structural maturation of the AJ, and the biogenesis and function
of the TJ. Although molecular analyses are now required to
determine precisely the role of JAM-1 in each of these processes,
this study has demonstrated the earliest known role for JAM-1
in blastocyst morphogenesis.
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